Results 1 to 10 of about 565,186 (153)

Dyserythropoiesis and Myelodysplasia in Thiamine-Responsive Megaloblastic Anemia Syndrome [PDF]

open access: yesClinical Case Reports (discontinued), 2020
The case of thiamine‐responsive megaloblastic anemia (TRMA) presented here speculates the need early diagnosis, continuous monitoring, follow‐up, and regulated treatment plan for the patients.
Fariba Tarhani   +2 more
exaly   +6 more sources

An Italian case series' description of thiamine responsive megaloblastic anemia syndrome: importance of early diagnosis and treatment [PDF]

open access: yesItalian Journal of Pediatrics, 2023
Background Individuals with thiamine-responsive megaloblastic anemia (TRMA) mainly manifest macrocytic anemia, sensorineural deafness, ocular complications, and nonautoimmune diabetes.
Francesca Di Candia   +13 more
doaj   +3 more sources

Cochlear implant and thiamine-responsive megaloblastic anemia syndrome [PDF]

open access: yesAnnals of Saudi Medicine, 2014
Thiamine-responsive megaloblastic anemia syndrome is a rare autosomal recessive disorder defined by the occurrence of megaloblastic anemia, diabetes mellitus, and bilateral sensorineural deafness, responding in varying degrees to thiamine treatment.
Abdulrahman Abdullah Hagr
doaj   +4 more sources

Thiamine responsive megaloblastic anemia syndrome associated with patent ductus arteriosus: First case report from Kashmir Valley of the Indian subcontinent [PDF]

open access: yesIndian Journal of Endocrinology and Metabolism, 2012
Thiamine responsive megaloblastic anemia syndrome, an autosomal recessive inherited disorder characterized by a triad of anemia, diabetes mellitus and sensorineural deafness is caused by a deficiency of a thiamine transporter protein.
Mohd Ashraf Ganie   +7 more
doaj   +3 more sources

Thiamine responsive megaloblastic Anemia and deafness: A rare case of Roger's syndrome with successful hearing rehabilitation by cochlear implantation [PDF]

open access: yesJournal of Otology
Thiamine responsive megaloblastic anemia (TRMA), also known as Roger's syndrome, is an exceptionally rare autosomal recessive disorder stemming from mutations in the SLC19A2 gene responsible for encoding a thiamine carrier protein.This syndrome manifests
Hetal Marfatia   +3 more
doaj   +3 more sources

A challenging diagnosis for thiamine transporter deficiency anemia (Rogers syndrome) in two young siblings: A rare case report [PDF]

open access: yesClinical Case Reports, 2023
We present these two cases to emphasize the necessity of critical thinking and high suspicion of the disease (Rogers syndrome) to avoid potentially fatal situations due to its rarity and the importance of early treatment.
Yara Deeb   +4 more
doaj   +3 more sources

Case Report: Genetic and Clinical Features of Maternal Uniparental Isodisomy-Induced Thiamine-Responsive Megaloblastic Anemia Syndrome [PDF]

open access: yesFrontiers in Pediatrics, 2021
Background: Thiamine-responsive megaloblastic anemia syndrome (TRMA) is a rare autosomal recessive hereditary disease due to mutations in SLC19A2. Some cases show familial inheritance.Case report: A female patient (from a gravida 1, para 1 mother) of 3.5
Pengjiang Kang   +5 more
doaj   +2 more sources

Thiamine-responsive megaloblastic anemia syndrome with novel compound heterozygous SLC19A2 mutations and thrombotic events: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Thiamine-responsive megaloblastic anemia syndrome represents a rare autosomal recessive condition originating from mutations in the SLC19A2 gene.
Francisco Xavier Jiménez   +7 more
doaj   +2 more sources

Rogers Syndrome, an Uncommon Cause of Megaloblastic Anemia: A Case Series [PDF]

open access: yesAdvanced Biomedical Research
The present case series describes two male children of 5 months and 11 months old, having diabetes mellitus and megaloblastic anemia, but with no syndromic symptoms or organ involvement.
Reshma Roshan   +4 more
doaj   +2 more sources

Whole exome sequencing identifies a new mutation in the SLC19A2 gene leading to thiamine‐responsive megaloblastic anemia in an Egyptian family [PDF]

open access: yesMolecular Genetics & Genomic Medicine, 2019
Background The Solute Carrier Family 19 Member 2 (SLC19A2, OMIM *603941) encodes the thiamine transporter 1 (THTR‐1) that brings thiamine (Vitamin B1) into cells.
Khalda Amr   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy